Bertrand Alluis

Bertrand Alluis is an accomplished CMC Director at Amolyt Pharma since May 2024, responsible for managing CMC activities and teams throughout the drug development process. Prior to this role, Bertrand served as Director of Projects at ADOCIA from 2008 to August 2023, leading project strategy, management, and project leaders. As a Project Leader for Insulins, Bertrand oversaw multiple insulin projects and managed key license agreements with Eli Lilly and Tonghua Dongbao. Earlier positions include Director and Head of the Analytical Department at ADOCIA, focusing on analytical method development and management of a substantial team, as well as Senior Scientist at Avadel Pharmaceuticals and Head of the Chemistry Department at Diatos, where Bertrand contributed to various analytical and synthesis projects. Bertrand is also pursuing a Ph.D. in Organic Chemistry at Université Claude Bernard Lyon 1.